|
SUMMARY OF GENITOURINARY CANCER MEETINGS
This site segment presents three genitourinary (GU) cancer meetings—the
2002 annual meeting cosponsored by the National Cancer Institute and the
Society of Urologic Oncology and two State of the Science (SOTS) meetings
sponsored by the National Cancer Institute on the GU cancers that have
been held since 1999. All meetings presented on this site share the common
purpose of disseminating recent advances in knowledge about GU cancers.
The
SUO meeting covered state-of-the-art issues related to a host of GU cancers.
This session was a discussion of issues by members of the urologic oncology
community at the National Institutes of Health. Urologic surgeons, medical
and radiation oncologists, research scientists, and fellows/residents
in training attended and participated.
To date,
GU State of the Science meetings have covered cancers of the superficial
bladder and prostate. Themes have included advances in diagnosis, treatment
planning and administration, therapy development - with emphasis on molecular
targets - and use of models of "clinical states" within a cancer
type for guiding all stages of disease management. The SOTS GU cancer
meetings provide a structured forum for interaction among clinician investigators
familiar with the needs, problems, and opportunities presented by GU cancer
and laboratory scientists working in the fields of molecular biology,
signal transduction and cell cycle control, cellular microenvironment,
angiogenesis, and imaging research. Participants in the meetings include
clinical investigators and basic scientists from academia, industry, and
the community, as well as representatives from patient advocacy organizations.
|